Literature DB >> 24876092

Excimer emission in norepinephrine and epinephrine drugs with α- and β-cyclodextrins: spectral and molecular modeling studies.

N Rajendiran1, T Mohandoss, J Thulasidasan.   

Abstract

The inclusion complexation behavior of norepinephrine (NORE) and epinephrine (EPIN) with native cyclodextrins (α-CD and β-CD) were investigated by UV-visible, fluorimetry, time-resolved fluorescence, SEM, TEM, FT-IR, (1)H NMR, DSC, powder XRD and PM3 methods. Single emission was observed in aqueous solution where as dual emission (excimer) noticed in the CD solutions. Both drugs form 1:1 drug-CD complexes in lower CD concentrations and 1:2 CD-drug2 complexes in the higher CD concentrations. Time-resolved fluorescence studies indicated that both drugs showed single exponential decay in water and biexponential decay in CD. Nano-sized self-aggregated particles of drug-CD were found by TEM studies. Molecular modeling studies indicated that aliphatic chain part of the drug was entrapped in the CD cavity. Thermodynamic parameters and binding affinity of complex formation of the CD were determined according to PM3 method. The PM3 results were in good agreement with the experimental results.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24876092     DOI: 10.1007/s10895-014-1361-8

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  19 in total

Review 1.  Exploiting cavities in supramolecular gels.

Authors:  Jonathan A Foster; Jonathan W Steed
Journal:  Angew Chem Int Ed Engl       Date:  2010-09-10       Impact factor: 15.336

2.  Study of interaction of proton transfer probe 1-hydroxy-2-naphthaldehyde with serum albumins: a spectroscopic study.

Authors:  Rupashree Balia Singh; Subrata Mahanta; Nikhil Guchhait
Journal:  J Photochem Photobiol B       Date:  2008-01-09       Impact factor: 6.252

Review 3.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.

Authors:  T Loftsson; M E Brewster
Journal:  J Pharm Sci       Date:  1996-10       Impact factor: 3.534

4.  Photophysical study of 3-acetyl-4-oxo-6,7-dihydro-12H-indolo[2,3-a]quinolizine in biomimetic reverse micellar nanocavities: a spectroscopic approach.

Authors:  Arabinda Mallick; Basudeb Haldar; Subhendu Maiti; Subhash Chandra Bera; Nitin Chattopadhyay
Journal:  J Phys Chem B       Date:  2005-08-04       Impact factor: 2.991

5.  Preparation and study on the solid inclusion complex of sparfloxacin with HP-beta-cyclodextrin.

Authors:  Jianbin Chao; Jiangsong Li; Dongping Meng; Shuping Huang
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2003-03-01       Impact factor: 4.098

Review 6.  The utility of cyclodextrins for enhancing oral bioavailability.

Authors:  Rebecca L Carrier; Lee A Miller; Imran Ahmed
Journal:  J Control Release       Date:  2007-08-16       Impact factor: 9.776

7.  Molecular Nanotube Aggregates of beta- and ggr-Cyclodextrins Linked by Diphenylhexatrienes.

Authors:  G Li; L B McGown
Journal:  Science       Date:  1994-04-08       Impact factor: 47.728

8.  Self-assembly vesicles made from a cyclodextrin supramolecular complex.

Authors:  Bo Jing; Xiao Chen; Xudong Wang; Chunjie Yang; Yizhou Xie; Huayu Qiu
Journal:  Chemistry       Date:  2007       Impact factor: 5.236

9.  Endotracheal epinephrine: a call for larger doses.

Authors:  Yossi Manisterski; Zvi Vaknin; Ron Ben-Abraham; Ori Efrati; Danny Lotan; Mati Berkovitch; Asher Barak; Zohar Barzilay; Gideon Paret
Journal:  Anesth Analg       Date:  2002-10       Impact factor: 5.108

10.  Modulation of excited-state intramolecular proton transfer reaction of 1-hydroxy-2-naphthaldehyde in different supramolecular assemblies.

Authors:  Bijan Kumar Paul; Anuva Samanta; Nikhil Guchhait
Journal:  Langmuir       Date:  2010-03-02       Impact factor: 3.882

View more
  1 in total

1.  Should we Routinely Reverse Neuromuscular Blockade with Sugammadex in Patients with a History of Heart Transplantation?

Authors:  Koichi Yuki; Rebecca Scholl
Journal:  Transl Perioper Pain Med       Date:  2020-01-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.